Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

Background. Unique challenges posed by emerging infectious diseases often expose inadequacies in the conventional phased investigational therapeutic development paradigm. The recent Ebola outbreak in West Africa presents a critical case-study highlighting barriers to faster development. During the o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Infect Dis
Päätekijät: Dodd, Lori E., Proschan, Michael A., Neuhaus, Jacqueline, Koopmeiners, Joseph S., Neaton, James, Beigel, John D., Barrett, Kevin, Lane, Henry Clifford, Davey, Richard T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2016
Aiheet:
Major Articles and Brief Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878725/
https://ncbi.nlm.nih.gov/pubmed/26908739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw061
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia